Thanks for sharing. I don't go over there very often anymore.

There was also that business recently—I believe it was posted on the IPIX website—about compassionate use. I wonder if that might apply to patients who were in the K-2a trial being able to continue treatment. That's really just a bit of hopeful thinking though.

Hope the oral formulation work is done expediently and K can go on to the next level of testing asap.